Ritaban Chakravarty

Title: Ritaban Chakravarty: Innovator in Targeted Temperature Management Systems

Introduction

Ritaban Chakravarty is a notable inventor based in Louisville, Colorado. He has made significant contributions to the field of medical technology, particularly in targeted temperature management systems. His innovative approach has led to the development of a unique patent that enhances patient care.

Latest Patents

Ritaban holds a patent for a self-sealing connector for gel pads. This invention is part of a targeted temperature management (TTM) system that includes a TTM module designed to provide TTM fluid and a pad that facilitates thermal energy transfer between the TTM fluid and a patient. The system features a fluid delivery line (FDL) with a hub at the distal end. The pad incorporates a connector with a flapper valve that alternates between open and closed positions based on its coupling with the FDL hub. When uncoupled, the flapper valve covers the openings of both the fluid delivery conduit and fluid return conduit. Upon coupling, the flapper valve deforms to establish fluid communication, enhancing the efficiency of the TTM system.

Career Highlights

Ritaban Chakravarty is currently employed at C. R. Bard, Inc., a company renowned for its innovative medical technologies. His work focuses on improving patient outcomes through advanced thermal management solutions. His dedication to innovation has positioned him as a key player in the medical device industry.

Collaborations

Ritaban collaborates with talented professionals in his field, including Sean E. Walker and Audrey Earnshaw. These partnerships foster a creative environment that drives innovation and enhances the development of new technologies.

Conclusion

Ritaban Chakravarty's contributions to targeted temperature management systems exemplify the impact of innovation in healthcare. His patent for a self-sealing connector demonstrates his commitment to improving patient care through advanced technology. His work at C. R. Bard, Inc. continues to influence the medical device industry positively.